We are live on !
Find out more
ArrowMark Colorado Holdings Portfolio holdings
AUM
$2.4B
Turnover
17.08%
1-Year Est. Return
42.85%
This Fund
S&P 500
This Quarter Est. Return
+29.14%
1 Year Est. Return
+42.85%
3 Year Est. Return
+92.48%
5 Year Est. Return
+88.6%
10 Year Est. Return
+599.19%
AUM
$2.4B
AUM Growth
-$1.36B
(-36%)
Cap. Flow
-$1.93B
Cap. Flow % of AUM
Cap. Flow %
-80.34%
Top 10 Holdings %
Top 10 Hldgs %
15.27%
Holding
322
New
29
Increased
32
Reduced
159
Closed
26
Avg Time Held
3.5
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Aerospace & Defense Inc
AADX
|
+$12M |
| 2 |
Landstar System
LSTR
|
+$10.1M |
| 3 |
Ralliant Corp
RAL
|
+$9.31M |
| 4 |
Alphabet Inc Depositary Shares Series A Preferred Stock
GOOGM
|
+$9.14M |
| 5 |
Omnicell
OMCL
|
+$8.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hinge Health
HNGE
|
+$67.3M |
| 2 |
Cimpress
CMPR
|
+$49.2M |
| 3 |
Axogen
AXGN
|
+$48.5M |
| 4 |
Sterling Infrastructure
STRL
|
+$48.4M |
| 5 |
RB Global
RBA
|
+$46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.13% |
| 2 | Industrials | 20.23% |
| 3 | Technology | 15.21% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Financials | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$51.2B
| $90M | 3.75% |
982,494
-287,529
| -23% | -$26.3M |
2024 Q3
7 quarters
|
|
2
MGM Resorts International
MGM
$7.2B
| $37M | 1.54% |
774,495
-77,306
| -9% | -$3.21M |
2021 Q3
19 quarters
|
|
3
Vistra
VST
$51B
| $35.5M | 1.48% |
224,009
-89,806
| -29% | -$13.9M |
2017 Q2
36 quarters
|
|
|
4
Axogen
AXGN
$2.03B
| $32.9M | 1.37% |
711,795
-1,203,644
| -63% | -$48.5M |
2018 Q1
33 quarters
|
|
5
AbCellera Biologics
ABCL
$3.82B
| $32.2M | 1.34% |
4,105,095
| – | – |
2023 Q2
12 quarters
|
|
6
Federal Signal
FSS
$6.86B
| $29.4M | 1.23% |
228,974
-394,774
| -63% | -$45.3M |
2024 Q3
7 quarters
|
|
|
7
RB Global
RBA
$15.6B
| $28.1M | 1.17% |
241,145
-437,222
| -64% | -$46M |
2013 Q3
51 quarters
|
|
|
8
Hinge Health
HNGE
$8B
| $27.8M | 1.16% |
335,489
-1,239,794
| -79% | -$67.3M |
2025 Q2
4 quarters
|
|
9
Cheniere Energy
LNG
$59.8B
| $27.3M | 1.14% |
114,105
-14,353
| -11% | -$3.57M |
2013 Q2
52 quarters
|
|
10
Definium Therapeutics
DFTX
$4.31B
| $26.5M | 1.1% |
564,069
-1,030,648
| -65% | -$25.5M |
2026 Q1
1 quarter
|
|
11
UnitedHealth
UNH
$360B
| $26.4M | 1.1% |
63,630
-3,075
| -5% | -$1.14M |
2024 Q4
6 quarters
|
|
12
Veracyte
VCYT
$3.47B
| $26M | 1.08% |
441,986
-932,117
| -68% | -$39.1M |
2020 Q1
25 quarters
|
|
13
Turning Point Brands
TPB
$1.26B
| $24.9M | 1.04% |
294,131
-451,292
| -61% | -$37.5M |
2021 Q3
19 quarters
|
|
14
Wells Fargo
WFC
$252B
| $24.4M | 1.02% |
295,580
+41,720
| +16% | +$3.35M |
2016 Q3
39 quarters
|
|
15
SPX Corp
SPXC
$8.32B
| $24.4M | 1.02% |
99,596
-117,822
| -54% | -$25.8M |
2025 Q4
2 quarters
|
|
16
Maze Therapeutics
MAZE
$1.53B
| $22.9M | 0.95% |
767,383
| – | – |
2025 Q3
3 quarters
|
|
17
Tango Therapeutics
TNGX
$3.72B
| $22.1M | 0.92% |
708,385
| – | – |
2023 Q4
10 quarters
|
|
18
Kirby Corp
KEX
$7.2B
| $22.1M | 0.92% |
162,464
-308,084
| -65% | -$44.1M |
2013 Q3
51 quarters
|
|
19
Churchill Downs
CHDN
$5.69B
| $20.9M | 0.87% |
232,896
-482,945
| -67% | -$43.3M |
2022 Q1
17 quarters
|
|
20
Trimble
TRMB
$13.9B
| $20.6M | 0.86% |
402,467
-618,608
| -61% | -$36.6M |
2014 Q4
46 quarters
|
|
21
Royalty Pharma
RPRX
$27.1B
| $20.5M | 0.85% |
366,199
-554
| -0.2% | -$28.8K |
2024 Q3
7 quarters
|
|
22
Tandem Diabetes Care
TNDM
$1.13B
| $19.6M | 0.82% |
1,299,586
-1,804,023
| -58% | -$31.5M |
2023 Q3
11 quarters
|
|
23
PDF Solutions
PDFS
$1.66B
| $19.4M | 0.81% |
274,537
-82,083
| -23% | -$4.07M |
2025 Q2
4 quarters
|
|
24
ON Semiconductor
ON
$28B
| $19.1M | 0.8% |
202,230
-400,964
| -66% | -$41.1M |
2018 Q4
30 quarters
|
|
25
Curtiss-Wright
CW
$18.6B
| $19.1M | 0.8% |
25,198
-62,344
| -71% | -$45.7M |
2023 Q3
11 quarters
|
|
Similar funds
ArrowMark Colorado Holdings's Q2 2026 Portfolio in Review
As of Q2 2026, ArrowMark Colorado Holdings held 322 positions worth $2.4B, down 36% from $3.76B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
ArrowMark Colorado Holdings withdrew a net $1.93B in Q2 2026, closing 26 positions and reducing 159 holdings. Its most notable exit was Merit Medical Systems, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Industrials and Technology.
Against the trend, ArrowMark Colorado Holdings opened a new position in Applied Aerospace & Defense Inc worth $13.9M.
- ArrowMark Colorado Holdings's largest Q2 2026 buy was Applied Aerospace & Defense Inc: 609,099 shares worth $13.9M.
- ArrowMark Colorado Holdings added most to Chipotle Mexican Grill in Q2 2026, an estimated $8.2M increase.
- ArrowMark Colorado Holdings's biggest Q2 2026 reduction was Hinge Health, cutting an estimated $67.3M.
- ArrowMark Colorado Holdings fully exited Merit Medical Systems in Q2 2026, selling an estimated $24M.
- ArrowMark Colorado Holdings's ten largest holdings make up 15% of its $2.4B portfolio in Q2 2026.
- ArrowMark Colorado Holdings opened 29 new positions and closed 26 in Q2 2026.
- ArrowMark Colorado Holdings's portfolio value fell 36% quarter-over-quarter to $2.4B.
Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.